Hospira
Hospira in US-wide recall of product due to contamination
January 25, 2017Medical Communications Contamination, Hospira, Pfizer
Hospira, a company owned by Pfizer, has been forced to recall a batch of injectable drugs due to “the presence …
ICU Medical to acquire Pfizer’s global infusion therapy business in $1 billion deal
October 6, 2016Medical Communications Hospira, ICU medical, Pfizer, acquisition, infusion
The $1 billion deal that will take place as ICU Medical Inc. take over Pfizer’s Hospira Infusion Systems will be …
Pfizer may sell off Hospira unit for $2 billion
January 14, 2016Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps
Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …
Pfizer completes $15 billion Hospira acquisition
September 4, 2015Biosimilar Drugs, Hospira, Pfizer, mergers and acquisitions
Pfizer has completed its acquisition of Illinois-based injectable drugs and infusion device specialist Hospira for around $15 billion.The deal, first announced …
Data supports switching to Hospira biosimilar for RA
June 10, 2015Research and Development, Sales and Marketing EULAR, Hospira, Janssen, RA, brett wells, celltrion, inflectra, rome
Findings presented at EULAR this week from the first real-world study in patients with rheumatic diseases supports switching from J&J’s …
Napp launches biosimilar in UK
February 25, 2015Research and Development, Sales and Marketing Hospira, Napp, Remicade, anti-TNF biologic, biosimilar, infliximab, remsima
Napp Pharmaceuticals has launched its own biosimilar version of an anti-TNF biologic in Europe paving the way for patient access …
Hospira recalls Propofol drug again
February 10, 2015Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol
Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …
Pfizer to buy Hospira for $17 billion
February 5, 2015Sales and Marketing Hospira, Humira, Pfizer, acquisition, biosimilars, merger
Pfizer has struck a deal with Hospira to acquire the company in a deal worth around $17 billion. Industry analysts …
Hospira closing US manufacturing plant
January 20, 2015Manufacturing and Production, Sales and Marketing Clayton, Hospira, Novo Nordisk, Vancomycin hydrochloride, illinois, manufacturing
US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting 250 workers. Manufacturing of products …
Hospira recalls drug due to storage hiccup
October 13, 2014Manufacturing and Production, Sales and Marketing FDA, Hospira, Vancocin, Vancomycin hydrochloride, lilly
Hospira has issued a recall of one lot of its injectable vancomycin hydrochloride in the US due to ‘uncontrolled storage …
Herceptin faces UK competition within months
April 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biocon, Herceptin, Hospira, Perjeta, breast cancer
Roche’s blockbuster breast cancer drug Herceptin may soon be under threat from copycat treatments after a court in the UK …
Pharma manufacturing news in brief
February 17, 2014Manufacturing and Production Advaxis, Alexion, Berkshire Sterile Manufacturing, Catalent, Hospira, Shire
Hospira has made significant progress in restoring quality compliance at its facilities in Rocky Mount and Austin, which were the …
Hospira’s Inflectra approved in Europe
September 10, 2013Research and Development, Sales and Marketing Hospira, Janssen, Remicade, biosimilars, inflectra
Hospira has been the first firm to meet the European Commission’s approval for a biosimilar monoclonal antibody therapy with its …
Remicade copies set for European entry
July 1, 2013Sales and Marketing CHMP, Hospira, Janssen, Remicade, arthritis, biosimilar
Janssen’s Remicade could soon come under generic pressure after a landmark recommendation by the CHMP. South Korean biotech Celltrion and …
Hospira Reappoints chief scientific officer
May 15, 2013Manufacturing and Production, Research and Development, Sales and Marketing Hospira
Injectable drugs and infusion tech firm Hospira has announced that Sumant Ramachandra has been reappointed to his role as senior …
Latest content
Five Facts about cardiovascular disease
